Pain and Inflammation Research

Although separate conditions, pain and inflammation are nearly always associated with each other. Pain is defined by the International Association for the Study of Pain (IASP) as 'an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage'. Inflammation is the tissue's immunologic response to injury, characterized by mobilization of white blood cells and antibodies, swelling, and fluid accumulation.

Pain and Inflammation Research Products Areas

Products for Pain and Inflammation Research - Page 76

  1. Cat.No. Product Name Information/Activity
  2. BCC4593 (-)-MK 801 (-)-Dizocilpine maleate ((-)-MK-801 maleate) is a less active (-)-enantiomer of Dizocilpine. (-)-Dizocilpine maleate is a selective and non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist with a Ki of 211.7 nM. (-)-Dizocilpine maleate has antidepressant effects. (-)-MK 801 chemical structure
  3. BCC4014 (+)-MK 801 Maleate Dizocilpine maleate (MK-801 maleate) is a potent, selective and non-competitive NMDA receptor antagonist with Kd of 37.2 nM in rat brain membranes. (+)-MK 801 Maleate chemical structure
  4. BCC5859 Norketamine hydrochloride 79499-59-5 Norketamine hydrochloride chemical structure
  5. BCC7895 NPEC-caged-D-AP5 1416943-27-5 NPEC-caged-D-AP5 chemical structure
  6. BCC5644 Pentamidine isethionate Pentamidine isethionate (MP-601205 isethionate) is an antimicrobial agent and interferes with DNA biosynthetics. Pentamidine isethionate inhibits parasite Leishmania infantum with an IC50 of 2.5 μM. Pentamidine isethionate is a potent and selective protein tyrosine phosphatases (PTPases) and phosphatase of regenerating liver (PRL) inhibitor. Pentamidine isethionate has the potential for Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia treatment. Antitumor and antibacterial activities. Pentamidine isethionate chemical structure
  7. BCC7308 PMPA (NMDA antagonist) 113919-36-1 PMPA (NMDA antagonist) chemical structure
  8. BCC5918 PPDA 684283-16-7 PPDA chemical structure
  9. BCC7309 PPPA 113190-92-4 PPPA chemical structure
  10. BCC6292 QNZ 46 QNZ46 is a NR2C/NR2D-selective NMDA receptor non-competitive antagonist (IC50 values are 3, 6, 229, and >300, >300 μM for NR2D, NR2C, NR2A, NR2B, and GluR1, respectively). QNZ 46 chemical structure
  11. BCC7129 Remacemide hydrochloride 111686-79-4 Remacemide hydrochloride chemical structure

Items 751 to 760 of 1162 total